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Abstract 
To understand the antibiotic resistance in Gram-negative bacteria, a key point 
is to investigate antibiotic accumulation which is defined by influx and efflux. Several 
methods exist to evaluate the membrane permeability and efflux pump activity but 
they present some disadvantages and limitations. An optimized spectrofluorimetric 
method using the intrinsic tryptophan fluorescence as internal standard as well as a 
complementary microfluorimetric assay following the time-course accumulation in 
intact individual cells have been developed. Comparing the latter population and 
single cell approaches can lead to the understanding of the phenotypic heterogeneity 
within a population. The two methodologies lead to the determination of parameters, 
concentration, accumulation rates, localization that contribute to emerging concepts 
(RTC2T, SICAR) with the aim to identify and detail the antibiotic chemotypes that are 
involved in influx/efflux. 
Keywords 
Antibiotic; bacterial imaging; drug efflux pumps; Gram-negative bacteria; multidrug 
resistance; transporters 
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Introduction 
For several years antibiotic resistance has been an increasing threat to public 
health, it now concerns all major bacterial pathogens and antibiotic classes. A key 
challenge in antibiotic therapy is to determine the parameters modulating the in 
cellulo drug concentration required for a therapeutic action [1-3]. In Gram-negative 
antibacterial research, the concern is to evaluate the antibiotic permeation across the 
outer and inner membranes that constitute the bacterial envelope [4-6]. Translocation 
through the membrane barriers to reach the inhibitory concentration inside the 
bacterium is a pivotal step for antibacterial molecules [7-12].  
The discovery and the development of new antimicrobials mostly rely on their 
capacity to reach critical concentrations (Cinh) at the vicinity of their intracellular target 
[13,14]. Despite several decades of studies focused on antibiotic activity against 
bacterial cells using different approaches, no consensus for the analysis of the 
kinetics and accumulation of antibacterial agents in individual bacterium and in 
bacterial populations exists to understand the drug translocation into living bacteria 
as a first step of drug action [15]. Currently the lack of appropriate assays is a 
substantial bottleneck for the optimization of new molecules regarding permeability 
and to increase antimicrobial activity in intact bacterial cells. TRANSLOCATION 
consortium supports the development of reliable and robust methods to quantify 
penetration and efflux processes in Gram-negative bacteria (see "TRANSLOCATION 
Project: www.imi.europa.eu/content/translocation; [13]).  
Several methods and protocols have been developed in order to quantify and 
visualize the intra-bacterial concentrations of antibiotics and the role of membrane-
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associated mechanisms of resistance in the accumulation of antibacterial drugs 
(Influx, Efflux). Studies performed during this last decade have increased our 
understanding of how individual bacterial cells and bacterial populations control the 
internal concentration of antibiotics by using appropriate transport systems. In 
addition, original ways are now available to investigate in depth the drug 
translocation across bacterial membranes. Mass spectrometry appears as a 
promising method to determine the intracellular accumulation of label-free 
compounds [14,16]. Ultimately, this approach might help to characterize the 
permeability of various potential drugs, quantify antibiotic accumulation and meet the 
requirements of high throughput structure-activity relationship programs. In the case 
of naturally fluorescent drugs, intracellular accumulation can be monitored using a 
deep ultraviolet (DUV) light source that allows the detection by 
microspectrofluorimetry [17,18]. For example, fluoroquinolone antibiotics contain a 
quantum-yield of fluorescence sufficient to monitor their accumulation and 
localization in bacterial cells without requiring any addition of external probe.  
The information obtained by using these new approaches, combined with the 
knowledge inherited from more traditional approaches, are critical for our 
understanding of drug transport and have implications for future strategies and for 
designing new drugs to combat antibiotic resistance. 
Therefore, it is important to provide a recent and thoughtful perspective to the 
community that discusses the recent methods available for studying antibiotic 
penetration and correlation to antibacterial activities. From these studies and others, 
a new perspective emerges on how to capture and correlate the modes of action and 
kinetics of antibiotic uptake inside bacterial cells. 
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Detection of efflux activity 
The tripartite RND efflux pump family is well conserved in clinically relevant 
Enterobacteriaceae such as Escherichia coli, Enterobacter and Klebsiella spp, 
Salmonella enterica, as well as in other Gram-negative pathogens like Acinetobacter 
baumannii, Neisseria gonorrhoeae, and Pseudomonas aeruginosa [8,12].  
Based on its broad range substrate selectivity and its high expression level in 
clinical resistant isolates, it is a major contributor to the MDR resistance in these 
species. The archetypal E. coli AcrAB-TolC (or MexAB-OprM in P. aeruginosa) is the 
best structurally characterized RND efflux complex, since the crystal structures of the 
individual AcrA, AcrB and TolC have been solved and assembled complexes have 
been proposed [19-27]. While structural models and dynamic simulations are 
relatively well advanced (see accompanying reviews in this special issue), the 
characterization of AcrAB-TolC (as well as other efflux pumps) from mechanistic and 
kinetic point of view remains mainly partial as it relies on the comparison of minimal 
inhibitory concentration (MIC) values between of wild-type and acrAB-tolC deleted 
strains. 
The radiolabeled assay 
The first assay developed to evaluate the efflux activity in bacterial cells was the 
measurement of radiolabeled drug accumulation in resistant strains [28-30]. The 
efflux activity was demonstrated in several MDR isolates by using CCCP or other 
poisons that collapse the energy component of the efflux, and consequently block the 
pump and restored the intracellular antibiotic concentration at a level similar to the 
normal susceptible reference strains. The radiolabeled assay presents some 
advantages about precision, sharpness of quantification but also large disadvantages 
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regarding the availability/production of marked molecules, safety protocols, internal 
controls, low spatial resolution and waste treatments. 
The ethidium bromide-agar based method 
The accumulation of ethidium bromide (EtBr) was used to follow the activity of 
efflux pump in various bacterial species [31,32]. Later, a simple and instrument-free 
method that uses agar plates containing increasing concentrations of EtBr, as a 
fluorescent efflux pump substrate, has been developed to detect the presence of 
active efflux in swabbed strains [33]. This method, called the EtBr-agar cartwheel 
method, has been validated to identify overexpression of efflux pumps that contribute 
to MDR phenotypes in collections of clinical strains [34-37]. Briefly, it is based on that 
the minimal concentration of EtBr (MEB) in agar that produces fluorescence 
associated to bacteria growing at the surface of the agar defines the maximum 
extrusion rate of this substrate. Data showed that the MEB of strains that 
overexpress efflux pumps is considerably higher than that of reference strains. An 
example of results applied to one reference (ATCC15038) and eight MDR strains of 
E. aerogenes is shown: E. aerogenes HMEA11 showed no fluorescence at 1.5 µg/ml
EtBr whereas the others including ATCC15038 fluoresced at 0.05 µg/ml EtBr (Figure 
1).  
The main disadvantage of this method is the toxicity of the used dye, EtBr, the 
corresponding safety protocols require during the assays and the waste treatments of 
plates, effluents, etc. Moreover, like other dyes, EtBr is not per se an antibiotic and it 
is difficult to correlate an internal concentration, to an antibiotic activity and a clinical 
relevance. 
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The semi-automated “real-time” method using fluorescent probes 
It was necessary to develop fast, easy-to-perform and reliable methods in order to 
study the real-time efflux of a pre-accumulated compound in bacteria expressing 
various efflux pumps.  
Automated methods are advantageous in that they allow quantification of influx 
and efflux levels on a real-time basis and can be set up for medium throughput 
analysis of bacterial strains. The readability and reliability of this approach requires (i) 
that the chosen molecule does not alter bacterial metabolic functions at the working 
ranges, exhibits a good penetration through the outer membrane (and inner 
membrane), is a substrate of efflux pumps and yields high signal only when inside 
the cells and (ii) a protocol that detects the variation of this signal when molecules 
are expelled by the efflux activity.  
Several fluorescent probes for which the spectroscopic properties change upon 
entering the cells are particularly appropriate for these assays: the bacterial cells can 
be preloaded with these dyes before triggering the efflux by adding an energy 
source. Two lipophilic compounds, Nile Red and 1,2’-dinaphthylamine(1,2’-DNA) that 
give negligible fluorescence in aqueous solutions but become strongly fluorescent in 
nonpolar environments such as bacterial membranes, have been described for 
measuring the efflux activity and the effect of putative efflux pump inhibitors [38-41]. 
After loading, cells are then energized by the addition of glucose, which produces the 
proton motive force in the inner membrane, energizes the RND pump and triggers 
the dye efflux across the envelope (Fig. 2). However, special attention should also be 
given to the self-quenching of the dye fluorescence in case of high concentration 
close to the bacterial membranes or to the quenching induced by other chemicals 
(e.g. efflux pump blockers/inhibitors) used in combination. In addition, similarly to 
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EtBr, these molecules are not antibiotics and the correlation between internal 
concentrations and antibacterial activities are not possible. Moreover, an internal 
standard is required to efficiently compare the data obtained in various bacterial 
series. The efflux activity was demonstrated in several MDR isolates by using CCCP 
or other poisons that collapse the energy component of the efflux, and consequently 
block the pump and restore the intracellular antibiotic concentration at a level similar 
to the normal susceptible reference strains. Interestingly, this approach can also be 
used to screen for molecules that inhibit efflux [40,42].  
Monitoring β-lactam efflux using rates of β-lactamase-mediated hydrolysis 
The knowledge of the kinetic behavior of efflux pumps is essential in our attempts 
to understand and quantify their contribution to antibiotic resistance. No success was 
achieved until the Nikaido laboratory determined the kinetic constants for several β-
lactams, including penicillins and cephalosporins, in intact cells of E. coli [43-45]. 
First, the intracellular concentration of β-lactams, which accumulate in the periplasm, 
was calculated by from their hydrolysis rate by periplasmic β-lactamases. Then, the 
rate of efflux was calculated as the difference between the calculated rate of influx 
and the measured rate of hydrolysis. Results obtained with nitrocefin — a 
chromogenic cephalosporin — showed a Km of about 5 µM and a Vmax around 0.025 
nmol/mg/s, which correspond to a kcat  10/s based on the cellular content of AcrB. 
Overall, penicillins present a stronger apparent affinity ( 1 µM) for AcrB than 
cephalosporins (ranging from 5 to 300 µM). In contrast to nitrocefin, the other 
cephalosporins had higher values of Km ( 20 µM for cefamandole,  90 µM for 
cephalotin,  300 µM for cephaloridine). Interestingly, this study showed that low 
affinity substrates such as cephaloridine are pumped out very efficiently (kcat  290/s) 
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when the periplasmic concentration exceeds 100 µM, which is far superior to the MIC 
for this antibiotic ( 0.5 µM). This finding pointed that efflux is not that important as 
long as it occurs in the range of intracellular concentration superior to the MIC. 
Determination of antibiotic accumulation in bacteria using UV fluorescence 
microscopy/spectroscopy methods 
Membrane-associated mechanisms of bacterial MDR (i.e. membrane 
impermeability and drug efflux) act to efficiently limit the concentration of antibiotics 
at the vicinity of their targets. Therefore, a key point in the understanding of these 
mechanisms is to determine and compare the intracellular concentration of antibiotics 
in bacterial cells accordingly to their phenotypic and genotypic status. Several 
approaches have been developed in the past by using plate assays [46,47] and 
fluorimetry [48], mainly for measuring the accumulation of tetracyclines and 
fluoroquinolones by Enterobacteriaceae as reported previously [49,50]. 
Quinolones are powerful antibiotics that inhibit the activity of DNA gyrase and 
topoisomerase IV enzymes located in the cytoplasm. The ability of quinolones to 
pass the bacterial membranes to reach their intracellular targets is a key factor for 
their activity. In Gram-negative bacteria, fluoroquinolones have been shown to use 
the outer membrane porins [51] to efficiently accumulate inside the cell. The 
mechanism of permeation across the inner membrane is less clear, but most likely 
involves an energy-independent passive diffusion mechanism. Moreover, quinolones 
are also excellent substrates of efflux pumps [52,53]. 
In 1989, Chapman & Georgopapadakou have developed a fluorimetric method 
based on the natural fluorescence of the quinolone nucleus present in 
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fluoroquinolones such as the clinically used ciprofloxacin and norfloxacin [48]. 
Several adaptations have improved the spectrofluorimetry of cell lysates and allow a 
precise quantification of the antibiotic content (in ng/bacterial cell) in a given bacterial 
cell using a calibration curve. Various publications report the determination of 
fluoroquinolone concentration in various bacterial species [14].  
An optimized method to determine the fleroxacin accumulation inside Enterobacter 
aerogenes resistant strains that overproduced AcrAB-TolC efflux pump has been 
recently reported [17]. After incubation, the bacterial cells are washed onto a sucrose 
cushion in order to overcome problems of reproducibility mainly caused by non-
specific adsorption of antibiotic molecules at the bacterial surface [17]. Moreover, 
special attention has be given to the spectral properties of the fluorescent molecule 
(fleroxacin, ciprofloxacin) in order to monitor its fluorescence signal in bacterial 
lysates and to integrate an internal fluorescence standard, the intrinsic tryptophan 
fluorescence, in the protocol [17,54]. These special improvements have allowed 
generating comparative assays between various bacterial strains and species 
[18,54,55]. Furthermore, this internal standard that insures the quantitative valuation 
of various drugs/antibiotics on different bacterial strains is necessary for a 
comparative validation of other methods (such as mass spectrometry) for which no 
intrinsic standard has been selected yet.  
About E. aerogenes and E. coli strains, the data indicate that the steady-state 
accumulation was stable after an incubation time of 10-15 minutes for the strains 
without AcrAB or overproducing the efflux pump. The CCCP addition during the 
assay with AcrAB overproducer strain restores the accumulation plateau observed in 
the acrAB deleted strain (Fig. 3). To reach the best validation and robustness interval 
of this approach it is absolutely required that the used molecule (i) does not kill the 
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bacteria at the used concentration during the incubation times, a parameter which 
can be checked by survival assays, (ii) exhibits a good penetration through the outer 
membrane (and inner membrane), (iii) is a substrate of efflux pumps as documented 
by the susceptibility determined in isogenic strains in parallel and by using efflux-
deleted cells or incubation in the presence of CCCP [17], and (iv) importantly cause 
non-overlapping signal with the intrinsic internal standard (e.g. tryptophan signal). 
Moreover, the signal must be detected in intact bacterial cell 
(microspectrofluorimetry) and in bacterial lysates by using the same antibiotic 
concentration and generate significant variation when molecules are expelled by the 
efflux activity. Interestingly, this method has indicated some discrepancy in the 
fluoroquinolone accumulation in a bacteria population issued from the same resistant 
strain treated with the ionophore suggesting some phenotypic heterogeneity [17]. 
Combining population and single cell approaches guarantee that, if several 
subpopulations with extreme behavior were present, they would not be 
underestimated. 
It can be noted that a fluorescent ß-lactam derivative has been recently used to 
study the antibiotic accumulation and susceptibility in bacterial persisters, a sub-
population dormant bacteria showing high level of tolerance to antibiotics [56]. 
Bocillin is a penicillin V molecule coupled to a fluorescein core, BODIPY FL dye 
(which is spectrally similar to fluorescein). This compound has been assayed to 
measure the activity of efflux pump on its intra-bacterial accumulation [57]. 
Interestingly, the authors reported that the internal accumulation of bocillin was 
significantly reduced in persisters due to the efflux activity of AcrAB-TolC pump [57]. 
Bocillin was also used for evaluating the role of efflux pump in the resistance of non-
typeable Haemophilus influenzae [58]. Although this fluorescent penicillin derivative 
12 
is an interesting tool, it must be mentioned that due to the involvement of porin 
channel during the uptake of this antibiotic family, an alteration of porin 
characteristics (expression level, porin type or channel conductance) can change the 
accumulation rate and consequently can perturb the determination of efflux activity 
[6,8]. 
Fluoroquinolone time-course accumulation in a single bacterial cell using UV 
fluorescence microscopy, microfluorimetric assay 
Optimized spectrofluorimetric and microscopic methods using appropriate 
calibration curves and internal standards have been developed to monitor the 
accumulation of fluoroquinolones in Enterobacteriaceae. More recently, these 
approaches have been modified for the measurement of antibiotic accumulation in 
intact individual cells: briefly the bacterial cells are deposited between two quartz 
coverslips and analysed by DUV microspectrofluorimetry and/or by DUV 
fluorescence imaging (Fig. 4). The cell viability was checked during the time 
exposure. With this protocol, the time-course of accumulation of selected 
fluoroquinolones can be recorded in different individual cells [54] and with various 
incubation conditions (antibiotic concentration, efflux blocker, etc). The rate of 
accumulation and the plateau reached after long time of incubation can be extracted 
for a given antibiotic and for a given strain [54]. 
These technologies will offer the opportunity to determine influx and efflux 
parameters such as the intracellular concentration of antibiotics (Cin), the critical 
inhibitory intracellular concentration of antibiotics (Cinh), the precise contribution of 
limiting factors in reaching a Cinh (e.g. porins and efflux pumps) and the influence of 
chemical moieties (pharmacophores) within a specific class of antibiotic. The 
13 
"Resident Time Concentration Close to Target" (RTC2T) concept includes the 
precise determination of both Cin, and Cinh for a given antibacterial molecule for a 
given bacterial strain [14]. It will be useful to quantify the biological activity of different 
adjuvants in increasing the intracellular concentration of specific antibiotics in strains 
exhibiting membrane-associated mechanisms of resistance. The translocation of 
antibiotics belonging to different classes through bacterial membranes via outer 
membrane pores or transporters (porins or efflux pumps) is a relatively fast event and 
the steady-state concentrations are generally reached after short incubation times. 
Monitoring real-time accumulation of different quinolones showed different 
accumulation kinetics and steady-state accumulation levels depending on the 
properties (chemical and structural) of the compound in a selected bacterial 
background. From these observations a new concept, "Structure Intracellular 
Concentration Activity Relationship" (SICAR) can be elaborated to dissect the profile 
of antibacterial molecules [14]. SICAR connects the physicochemical drug properties 
to the efficacy of translocation through the bacterial membrane and the resulting 
intracellular accumulation [59]. 
These concepts have been recently used to dissect the role of chemical structures 
and the bacterial elements which are involved in influx (uptake) or in efflux, and guide 
rationale pharmacomodulation of side chains to fine-tune molecular interactions with 
membrane transporters. Two cases have been studied so far: an antibiotic having a 
periplasmic target and one having a cytoplasmic target, this gives the possibility to 
integrate the aspect about the cellular location.  
Ceftazidime (CAZ) is a potent cephalosporin to treat resistant bacteria in 
combination with ß-lactamase inhibitors [60]. Different fluorescent derivatives have 
been synthesized to dissect the early step of translocation across bacterial outer 
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membrane: CAZ* is labeled with a coumarin and its fluorescent signal is not affected 
by cleavage by periplasmic ß-lactamases, and CAZ** is labeled with 
methoxyquinoline but becomes fluorescent only upon cleavage by periplasmic ß-
lactamases [55]. The measure of internal accumulation and activities are performed 
on clinical resistant strains expressing various levels of porins and ß-lactamases. By 
using microspectrofluorimetry and epifluorimetry, the translocation of CAZ to the 
periplasmic space was followed when the outer membrane barrier was permeabilized 
[55]. This study demonstrated the relationship between periplasmic accumulation and 
antibiotic activity by approaching ß-lactam permeation relative to membrane 
permeability. Moreover, a correlation between internal accumulation and ß-lactamase 
activity was provided that supports the pioneer model proposed by H. Nikaido to 
explain the interplay existing between the membrane and enzymatic barrier for ß-
lactams [61,62]. 
Three selected fluoroquinolones have been studied for their accumulation in 
bacterial population and inside individual Gram-negative bacterial cells that express 
various levels of efflux pumps. For a given fluoroquinolone library, these assays 
allowed the determination of SICARIN and SICAREF indexes, the first one reflects 
“structure-to-penetration” relationships and the second one illustrates the correlation 
“structure-to-efflux”. This original approach validates the SICAR concept [14,59] and 
demonstrates the expected benefit by evidencing some pharmacophoric groups that 
can be involved in the penetration and in the efflux.  
Reconstitution of efflux pumps in proteoliposomes 
Active drug transport by efflux pumps has also been investigated after 
reconstitution of purified proteins into proteoliposomes. A major difficulty is to 
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generate quantitatively measurable and reproducible proton gradient across the 
liposome membrane. Primary in vitro transport assay has been designed by the 
Nikaido laboratory, in which reconstituted E. coli AcrB were energized by a proton 
gradient generated by the addition of valinomycin, a potassium-ionophore [63]. 
Detection of proton transport was monitored using pyranine, a lipophilic and pH-
dependent fluorescent probe. However, the stability of the valinomycin-generated 
ΔpH was strongly influenced by the batches of lipids used for reconstitution and other 
factors [64]. To overcome this problem, Picard and colleagues have developed an 
original system in which they used bacteriorhodopsin (BR) from Halobacter halobium 
to generate a photo-induced proton gradient to activate the MexB efflux pump from 
P. aeruginosa [65]. In this system, BR, MexA and MexB were reconstituted in
liposomes containing pyranine. After illumination of the proteoliposomes, BR 
generates a transmembrane proton gradient, which is then used by MexB to 
transport a fluorescent dye (Hoechst 33342). In this assay, pyranine fluorescence is 
monitored while the proton gradient is generated or dissipated as a result of MexB 
efflux activity (Fig. 5). Curves show that MexB is active only in the presence of the 
periplasmic adaptor MexA. Recently, significant improvements of this method have 
been made by combining proteoliposomes containing the MexAB and OprM portions 
of the complex. This allowed monitoring of transport by the tripartite MexAB-OprM 
pump in a system that mimics the dual-membrane architecture of Gram-negative 
bacteria [26, 66]. 
Conclusion 
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Today with the development of DUV-fluorimetry method and apparatus, new tools 
have been proposed for studying the drug translocation across biological membrane 
and in living cells including bacterial population and individual bacterial cells.  
Boosted by emerging and upgraded methodologies (detector, filters, etc), new 
concepts such as “Structure Intracellular Concentration Activity Relationship” 
(SICAR) and "Resident Time Concentration Close to Target" (RTC2T), have been 
proposed in order to bridge the molecular and membrane transport aspects [14]. 
Using RTC2T and SICAR methodologies, a new dissection of antibiotic translocation-
transport can be defined to better understand and improve the antibiotic chemotypes 
that are related to permeation and efflux. The final objective will be to enhance the 
antibacterial efficacy of a rationally synthetized antibiotic against a resistant species.  
A second important aspect is the complex relation integrating 
"kinetics/localization/concentration" inside the bacterial cell and the effect on bacterial 
metabolism and cell life. An important step is to correlate the intracellular 
concentration threshold and antibacterial activity for the antibiotic molecule and also 
for new "adjuvants" that can improve the antibiotic concentration inside the 
bacterium. 
Conclusively, the use of this methodology that measures the real-time 
accumulation in different bacterial phenotypes and takes into account various 
chemical structures, allows analyzing the molecular bases of drug translocation. 
Consequently, the concept of "structure intracellular concentration activity 
relationship" previously proposed [14] can be extensively studied for fluorescent 
antibiotics. Regarding non-fluorescent molecules, a competitive assay can be 
designed to indirectly measure these parameters, or alternatively mass spectrometry 
quantification can be successfully applied [67-69]. About mass spectrometry, the 
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precision of the method asks for a robust internal standard that could be used to 
standardize the assays carried out with various bacterial species and various strains 
including clinical isolates. 
By using these methods available in microplates, the role of chemical side chains 
involved in the membrane permeation or in the efflux transport [59] can be dissected 
to better design drug side chains fitting well with the translocation constraints.  
The future step will be the development of microfluidic-microfluorimetric approach 
that detect two events in the same bacterial cell, influx and efflux. This detection, 
should finally allow the discrimination inside the population of susceptible 
(fluorescence signal) and low-susceptible (no signal) individual bacteria present 
under specific conditions. This multiplexed approach paves the way for studying the 
diversity in the population, the presence of persisters, and the role of membrane-
associated mechanisms of resistance in the bacterial response face to the antibiotic 
stimulus. 
18 
Conflict of interest 
No conflict 
Acknowledgements 
We thank Anne Davin-Regli, Robert Stavenger and Mathias Winterhalter for 
their fruitful discussions. 
The research leading to the discussions presented here was conducted as 
part of the TRANSLOCATION consortium and has received support from the 
Innovative Medicines Initiatives Joint Undertaking under Grant Agreement n°115525, 
resources which are composed of financial contribution from the European Union’s 
seventh framework program (FP7/2007-2013) and EFPIA companies in kind 
contribution. 
This work was also supported by Aix-Marseille Univ. and Service de Santé des 
Armées, and by Soleil program. 
19 
References 
1 Jones D. News and analysis: the antibacterial lead discovery challenge. 
Nat RevDrug Discov 2010;9:751–2. 
2 Watkins RR, Bonomo R. A. Overview: global and local impact of antibiotic 
resistance. Infect Dis Clin North Am 2016;30:313-22. 
3 Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, 
et al. Access to effective antimicrobials: a worldwide challenge. Lancet 
2016;387:168-75.  
4 Nikaido H. Molecular basis of bacterial outer membrane permeability 
revisited. Microbiol Mol Biol Rev 2003;67:593-656. 
5 Zgurskaya HI, López CA, Gnanakaran S. Permeability barrier of Gram-
negative cell envelopes and approaches to bypass it. ACS Infect Dis 
2015;1:512-522. 
6 Pagès JM, James CE, Winterhalter M. The porin and the permeating 
antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev 
Microbiol 2008;6:893–903. 
7 Nikaido H. Prevention of drug access to bacterial targets: permeability 
barriers and active efflux. Science 1994;264:382-8. 
8 Nikaido H, Pagès JM. Broad-specificity efflux pumps and their role in 
multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 
2012;36:340-63. 
9 Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, 
et al. Membrane permeability and regulation of drug "influx and efflux" in 
enterobacterial pathogens. Curr Drug Targets 2008;9:750-9. 
20 
10 Bolla JM, Alibert-Franco S, Handzlik J, Chevalier J, Mahamoud A, Boyer 
G, et al. Strategies for bypassing the membrane barrier in multidrug 
resistant Gram-negative bacteria. FEBS Lett 2011;585:1682-90. 
11 Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic 
resistance in Gram-negative bacteria. Clin Microbiol Rev 2015;28:337-418. 
12 Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular 
mechanisms of antibiotic resistance. Nat Rev Microbiol 2015;13:42-51.  
13 Stavenger, RA, Winterhalter M. TRANSLOCATION project: how to get 
good drugs into bad bugs. Sci Transl Med 2014;6:228ed7. 
14 Masi M, Réfrégiers M, Pos KM, Pagès JM.  Mechanisms of envelope 
permeability and antibiotic influx/efflux in Gram negative bacteria. Nat 
Microbiol 2017;2:17001. 
15 Krishnamoorthy G, Wolloscheck D, Weeks JW, Croft C, Rybenkov VV, 
Zgurskaya HI. Breaking the permeability Barrier of Escherichia coli by 
controlled hyperporination of the outer membrane. Antimicrob Agents 
Chemother. 2016;60:7372-81. 
16 Zhou Y, Joubran C, Miller-Vedam L, Isabella V, Nayar A, Tentarelli S et al. 
Thinking outside the “bug”: a unique assay to measure intracellular drug 
penetration in gram-negative bacteria. Anal Chem 2015 ;87 :3579–84. 
17 Kaščáková S, Maigre L, Chevalier J, Réfrégiers M, Pagès JM. Antibiotic 
transport in resistant bacteria: synchrotron UV fluorescence microscopy to 
determine antibiotic accumulation with single cell resolution. PLoS ONE 
2012;6:e38624.  
21 
18 Pagès JM, Kascàkovà S, Maigre L, Allam A, Alimi M, Chevalier J, et al. 
New Peptide-based antimicrobials for tackling drug resistance in bacteria: 
single-cell fluorescence imaging. ACS Med Chem Lett 2013;4:556-9. 
19 Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C. Crystal structure of 
the bacterial membrane protein TolC central to multidrug efflux and protein 
export. Nature 2000;405:914-9. 
20 Symmons MF, Bokma E, Koronakis E, Hughes C, Koronakis V. The 
assembled structure of a complete tripartite bacterial multidrug efflux 
pump. Proc Natl Acad Sci U S A 2009;106:7173-8. 
21 Du D, van Veen HW, Murakami S, Pos KM, Luisi BF. Structural and 
functional aspects of the multidrug efflux pump AcrB. Biol Chem 
2009;390:693-9.  
22 Pei XY, Hinchliffe P, Symmons MF, Koronakis E, Benz R, Hughes C, 
Koronakis V. Structures of sequential open states in a symmetrical opening 
transition of the TolC exit duct. Proc Natl Acad Sci U S A 2011;108:2112-7. 
23 Hinchliffe P, Symmons MF, Hughes C, Koronakis V. Structure and 
operation of bacterial tripartite pumps. Annu Rev Microbiol 2013;67:221-42. 
24 Yamaguchi A, Nakashima R, Sakurai K. Structural basis of RND-type 
multidrug exporters. Front Microbiol 2015;6:327. 
25 Müller RT, Pos KM. The assembly and disassembly of the AcrAB-TolC 
three-component multidrug efflux pump. Biol Chem 2015;396:1083-9.  
26 Daury L, Orange F, Taveau JC, Verchère A, Monlezun L, Gounou C, 
Marreddy RK, Picard M, Broutin I, Pos KM, Lambert O. Tripartite assembly 
of RND multidrug efflux pumps. Nat Commun 2016;7:10731. 
22 
27 Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, Venter H, 
Chiu W, Luisi BF. Structure of the AcrAB-TolC multidrug efflux pump. 
Nature  2014;509:512-15. 
28 Cohen SP, Hooper DC, Wolfson JS, Souza KS, McMurry LM, Levy SB. 
Endogenous active efflux of norfloxacin in susceptible Escherichia coli. 
Antimicrob Agents Chemother 1988;32:1187-91. 
29 Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-
resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) 
Escherichia coli selected by tetracycline or chloramphenicol: decreased 
drug accumulation associated with membrane changes in addition to 
OmpF reduction. Antimicrob Agents Chemother 1989;33:1318-25.  
30 Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic 
resistance of Pseudomonas aeruginosa: resistance to tetracycline, 
chloramphenicol, and norfloxacin Antimicrob Agents Chemother 
1994;38:1732-41. 
31 Ocaktan A, Yoneyama H, Nakae T. Use of fluorescence probes to monitor 
function of the subunit proteins of the MexA-MexB-OprM drug extrusion 
machinery in Pseudomonas aeruginosa. J Biol Chem 1997;272:21964-9.  
32 Germ M, Yoshihara E, Yoneyama H, Nakae T. Interplay between the efflux 
pump and the outer membrane permeability barrier in fluorescent dye 
accumulation in Pseudomonas aeruginosa. Biochem Biophys Res 
Commun 1999;261:452-5. 
33 Martins M, Santos B, Martins A, Viveiros M, Couto I, Cruz A, et al. 
Management Committee Members; of Cost B16; European 
Commission/European Science Foundation. An instrument-free method for 
23 
the demonstration of efflux pump activity of bacteria. In Vivo 2006;20:657-
64. 
34 Martins A, Spengler G, Martins M, Rodrigues L, Viveiros M, Davin-Regli A, 
et al. Physiological characterisation of the efflux pump system of antibiotic-
susceptible and multidrug-resistant Enterobacter aerogenes. Int J 
Antimicrob Agents 2010;36:313-8. 
35 Martins M, Viveiros M, Couto I, Costa SS, Pacheco T, Fanning S, et al. 
Identification of efflux pump-mediated multidrug-resistant bacteria by the 
ethidium bromide-agar cartwheel method. In Vivo 2011;25:171-8. 
36 Martins M, McCusker MP, Viveiros M, Couto I, Fanning S, Pagès JM, et al. 
A simple method for assessment of MDR bacteria for over-expressed efflux 
pumps. Open Microbiol J 2013;7:72-82. 
37 Viveiros M, Martins A, Paixão L, Rodrigues L, Martins M, Couto I, Fähnrich 
E, Kern WV, Amaral L. Demonstration of intrinsic efflux activity of 
Escherichia coli K-12 AG100 by an automated ethidium bromide method. 
Int J Antimicrob Agents 2008;31:458-62. 
38 Bohnert JA, Karamian B, Nikaido H. Optimized Nile Red efflux assay of 
AcrAB-TolC multidrug efflux system shows competition between 
substrates. Antimicrob Agents Chemother 2010;54:3770-5.  
39 Bohnert JA, Schuster S, Szymaniak-Vits M, Kern WV. Determination of 
real-time efflux phenotypes in Escherichia coli AcrB binding pocket 
phenylalanine mutants using a 1,2'-dinaphthylamine efflux assay. PLoS 
ONE 2011;6:e21196. 
40 Bohnert JA, Schuster S, Kern WV, Karcz T, Olejarz A, Kaczor A, et al. 
Novel piperazine arylideneimidazolones inhibit the AcrAB-TolC pump in 
24 
Escherichia coli and simultaneously act as fluorescent membrane probes 
in a combined real-time influx and efflux assay. Antimicrob Agents 
Chemother 2016;60:1974-83.  
41 Husain F, Nikaido H. Substrate path in the AcrB multidrug efflux pump of 
Escherichia coli. Mol Microbiol 2010;78:320-30. 
42 Misra R, Morrison KD, Cho HJ, Khuu T. Importance of real-time assays to 
distinguish multidrug efflux pump inhibiting and outer membrane 
destabilizing activities in Escherichia coli. J Bacteriol 2015;197:2479-88. 
43 Nagano K, Nikaido H. Kinetic behavior of the major multidrug efflux pump 
AcrB of Escherichia coli. Proc Natl Acad Sci U S A. 2009; 106:5854-5858.  
44 Lim SP, Nikaido H. Kinetic parameters of efflux of penicillins by the 
multidrug efflux transporter AcrAB-TolC of Escherichia coli. Antimicrob 
Agents Chemother. 2010; 54:1800-1806. 
45 Kinana AD, Vargiu AV, May T, Nikaido H. Aminoacyl β-naphthylamides as 
substrates and modulators of AcrB multidrug efflux pump. Proc Natl Acad 
Sci U S A. 2016;113:1405-1410. 
46 Hirai K, Aoyama H, Irikura T, Iyobe S, Mitsuhashi S. Differences in 
susceptibility to quinolones of outer membrane mutants of Salmonella 
typhimurium and Escherichia coli. Antimicrob Agents Chemother 
1986;29:535-8. 
47 Hirai K, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. Mutations producing 
resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob Agents 
Chemother 1987;31:582-6. 
48 Chapman JS, Georgopapadakou NH. Fluorometric assay for fleroxacin 
uptake by bacterial cells. Antimicrob Agents Chemother 1989;33:27-9. 
25 
49 De Zeeuw JR. Accumulation of tetracyclines by Escherichia coli. J 
Bacteriol 1968;95:498-506. 
50 Mortimer PG, Piddock LJ. A comparison of methods used for measuring 
the accumulation of quinolones by Enterobacteriaceae, Pseudomonas 
aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 
1991;28:639-53. 
51 Chevalier J, Malléa M, Pagès JM. Comparative aspects of the diffusion of 
norfloxacin, cefepime and spermine through the F porin channel of 
Enterobacter cloacae. Biochem J 2000;348:223-7. 
52 Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A. The AcrB 
multidrug transporter plays a major role in high-level fluoroquinolone 
resistance in Salmonella enterica serovar typhimurium phage type DT204. 
Microb Drug Resist 2002; 8:281-9. 
53 Yu EW, Aires JR, McDermott G, Nikaido H. A periplasmic drug-binding site 
of the AcrB multidrug efflux pump: a crystallographic and site-directed 
mutagenesis study. J Bacteriol 2005;187:6804-15. 
54 Cinquin B, Maigre L, Pinet E, Chevalier J, Stavenger RA, Mills S, et al. 
Microspectrometric insights on the uptake of antibiotics at the single 
bacterial cell level. Sci Rep 2015 ;5 :17968. 
55 Allam A, Maigre L, Vergalli J, Dumont E, Cinquin B, Alves de Sousa R, et 
al. Microspectrofluorimetry to dissect the permeation of ceftazidime in 
Gram-negative bacteria. Sci Rep 2017;7:986. 
56 Zhao G, Meier TI, Kahl SD, Gee KR, Blaszczak LC. Bocillin FL, a sensitive 
and commercially available reagent for detection of penicillin-binding 
proteins. Antimicrob Agents Chemother 1999;43 :1124-8. 
26 
57 Pu Y, Zhao Z, Li Y, Zou J, Ma Q, Zhao Y, et al. Enhanced efflux activity 
facilitates drug tolerance in dormant bacterial cells. Mol Cell 2016;62:284-
94. 
58 Cherkaoui A, Diene SM, Renzoni A, Emonet S, Renzi G, François P, et al. 
Imipenem heteroresistance in nontypeable Haemophilus influenzae is 
linked to a combination of altered PBP3, slow drug influx and direct efflux 
regulation. Clin Microbiol Infect 2017;23:118.e9-118.e19. 
59 Vergalli J, Dumont E, Cinquin B, Maigre L, Pajovic J, Bacqué E, Mourez M, 
Réfrégiers M, Pagès JM. Fluoroquinolone structure and translocation flux 
across bacterial membrane. Sci Rep 2017;7:9821. 
60 Pagès JM, Peslier S, Keating TA, Lavigne JP, Nichols WW. Role of the 
outer membrane and porins in susceptibility of β-lactamase-producing 
Enterobacteriaceae to ceftazidime-avibactam. Antimicrob Agents 
Chemother 2015;60:1349-59. 
61 Nikaido H. Role of permeability barriers in resistance to ß-lactams 
antibiotics.  Pharmac Ther 1985;27:197-231. 
62 Nikaido H. Outer membrane barrier as a mechanism of antimicrobial 
resistance. Antimicrob Agents Chemother 1989;33:1831-6. 
63 Zgurskaya HI, Nikaido H. Bypassing the periplasm: reconstitution of the 
AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci U S A. 
1999;96:7190-5. 
64 Picard M, Verchère A, Broutin I. Monitoring the active transport of efflux 
pumps after their reconstitution into proteoliposomes: caveats and keys. 
Anal Biochem 2012;420:194-6. 
27 
65 Verchère A, Broutin I, Picard M. Photo-induced proton gradients for the in 
vitro investigation of bacterial efflux pumps. Sci Rep 2012;2:306. 
66 Verchère A, Dezi M, Adrien V, Broutin I, Picard M. In vitro transport activity 
of the fully assembled MexAB-OprM efflux pump from Pseudomonas 
aeruginosa. Nat Commun 2015;6:6890. 
67 Davis TD, Gerry CJ, Tan DS. General platform for systematic quantitative 
evaluation of small-molecule permeability in bacteria. ACS Chem Biol 
2014;9:2535-44. 
68 Brown AR, Ettefagh KA, Todd D, Cole PS, Egan JM, Foil DH, et al. A mass 
spectrometry-based assay for improved quantitative measurements of 
efflux pump inhibition. PLoS ONE 2015;10:e0124814.  
69 Richter MF, Drown BS, Riley AP, Garcia A, Shirai T, Svec RL, et al. 
Predictive compound accumulation rules yield a broad-spectrum antibiotic. 
Nature 2017;545:299-304. 
28 
Legends for Figures 
Figure 1: Identification of efflux pump-mediated multidrug-resistant bacteria by the 
ethidium bromide-agar cartwheel method.  
Left: Cartwheel pattern for the swabbing of the bacterial strains tested by the EtBr-
agar cartwheel method. Controls and clinical isolates were swabbed on an EtBr-
containing agar plate, according to the diagram.  
Right: Example of the EtBr-agar cartwheel method applied to Enterobacter 
aerogenes strains on agar plates containing 1.5 mg/l of EtBr. Following overnight 
incubation at 37°C for 16 hours, fluorescence was detected under UV light. (from 
[34]). 
Figure 2: Real-time efflux assay using fluorescent probes. 
(A) Protocol of the real-time efflux method. The cells are preloaded with a dye which
is fluorescent in nonpolar environments such as bacterial membranes. Addition of 
glucose energizes the efflux pump and triggers the dye efflux across the envelope, 
leading to the decrease of fluorescence.  
(B) Representative 1,2′-DNA efflux curves of E. aerogenes EA289, a clinical isolate
overexpressing AcrAB efflux pumps, and EA298 its tolC- derivative. Fluorescence of 
the AcrAB overexpressing strain is decreasing while the fluorescence of the strain 
devoid of TolC is stable. 
Figure 3: Determination of antibiotic concentration in bacteria using 
spectrofluorimetry. 
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(A) Protocol of the spectrofluorimetry method: After incubation of bacteria with the 
antibiotic, bacteria cells are washed onto a sucrose cushion in order to avoid non-
specific adsorption on the cell surface. The cells are then lysed overnight and the 
fluorescence intensity of the intracellular content is measured.  
(B) Representative fluorescence curves corresponding to the lysates of the
overexpressing AcrAB efflux pump strain E. aerogenes EA289 and its tolC- derivative 
strain EA298, incubated with fleroxacin with or without CCCP.  
Upper panel: kinetic of fleroxacin accumulation in the cells during 1h of incubation.  
Lower panel: Peaks of fluorescence (corresponding to the fleroxacin emission 
wavelength) of the lysates sampled at 15 minutes of incubation. 
Figure 4: Fluoroquinolone time-course accumulation in individual bacterial cells 
using DUV microspectrofluorimetry.  
(A) Average fluorescence intensity time course of 100 individual cells of the
overexpressing AcrAB efflux pump strain E. aerogenes EA289 (solid line) and its 
tolC- derivative strain EA298 (dashed line) incubated with fleroxacin. (from [53]).  
(B) Images taken by microscopy of isolated bacterium accumulating fleroxacin. (C)
Antibacterial activities and spectral properties of fleroxacin. MIC (Minimal inhibitory 
concentration) are indicated in mg/L; PMBN (Polymyxin B nonapeptide) was used at 
51.2 mg/L, PAßN (Phenylalanine-arginine-ß-naphthylamide) at 20 mg/L and CCCP 
(carbonyl cyanide m-chlorophenylhydrazone) at 10 µM. (D) Scheme of the 
translocation of fleroxacin (FLX) in a gram-negative bacterial cell. [FLX]ext: 
Concentration of fleroxacin in the external environment, [FLX]pp in the periplasmic 
space, [FLX]cyt in cytoplasm.  
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Figure 5: Reconstitution of efflux pumps in proteoliposomes. 
(A) Schematic representation of the MexA-MexB-OprM pump from Pseudomonas
aeruginosa (Adapted from [64]). 
(B) Cartoon representation of liposomes reconstituted with bacteriorhodopsin (BR)
from Halobacter halobium (upper scheme) or with both BR and MexB were 
reconstituted in liposomes containing pyranine (lower scheme). BR is used to 
generate a photo-induced proton gradient to activate the MexB efflux pump. After 
illumination of the proteoliposomes, BR generates a transmembrane proton gradient, 
which is then used by MexB to transport a fluorescent dye. (C) Monitoring of the 
liposomal acidification upon illumination. Pyranine fluorescence variations, as a result 
of MexB efflux activity, were normalized to the corresponding pH variations based on 
titration of the fluorescence variation as a function of pH. MexB is active only in the 
presence of the periplasmic adaptor MexA. 
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Figure1
Overnight grown bacterial culture in rich medium 
Step # 1 Overnight accumulation of dye in minimal nutrient conditions 
Spin down cells and resuspend in Mg-PPB to OD  0.25 
Add dye [1,2’-DNA] = 32 µM and [CCCP] = 5 µM and incubate o/n at 37°C 
Step # 2 Control dye accumulation 
Spin down cells, wash and transfer 100 µl into wells of blackflat bottom 96 
well half area microplates  and read fluorescence (370/421 nm 
excitation/emission) 
Step # 3 Monitor dye efflux 
Add 5 µl of 1 M glucose and monitor fluorescence decrease for 5 minutes 
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Bacterial culture (OD600  0.6) 
Spin down cells and resuspend in phosphate buffer to OD  6 
Step # 1 Antibiotic accumulation 
Add antibiotic [FLX] = 64 µg/ml  (8 MIC of the most sensitive strain) 
 [CCCP] = 10 µM
Incubate at 37°C 
Step # 2 Stop accumulation and remove non-specific absorbance 
Spin down 400 µl of cells on top of 550 µl of 1M sucrose solution 
Step # 3 Cell lysis 
Add 500 µl of HCl-glycine pH 3 
Incubate o/n at room temperature 
Step # 4 Acquisition of fluorescence 
Spin down, transfer 100 µl of clear lysates into wells of flat bottom 96 well half 
area microplates and read fluorescence (283/451 nm excitation/emission) 
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Reviewers' comments and responses in blue 
Reviewer #1: No comments 
Reviewer #2: The manuscript is now almost ready for acceptance. We thank the 
authors for addressing most of our questions.  However, we point that the following 3 
points are still missing: 
point #1 
initial question: 
L110: Indeed, crystal structures of the individual proteins have been determined but 
one should also acknowledge the recent EM data provided by Luisi and 
collaborators, as well as that of Lambert and collaborators, that brings light to the 
overall assembly of the pump.    
response of the authors: 
-> References to the work of Lambert and coll. and others have been added. Luisi 
and coll. solved MacAB-TolC, which belongs to another superfamily of efflux pumps. 
point that still must be corrected: 
>>> Ben Luisi and colleagues have recently solved the MacAB TolC but they have 
also described the AcrABTolC pump, see following paper : Du, D., Wang, Z., James, 
N.R., Voss, J.E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., and Luisi, B.F.
(2014). Structure of the AcrAB-TolC multidrug efflux pump. Nature 509, 512-515.
Thanks, this reference has been added. 
point #2 
initial question: 
L82-84: the authors never state why deep UV is mandatory compared to classical UV 
fluorescence.  
responses of the authors: 
-> The absorbance of quinolones molecules being maximum between 220 and 340 
nm (depending of the molecule studied), classical UV fluorescence (below 470 nm) 
cannot be used. This distinction is mandatory in microscopy were UV fluorescence 
microscopy is between 340 and 420 nm with a strong transmission drop below 350 
nm; however, in spectrometry, UV spectrometry would cover this range and the 
distinction is not necessary.  
& initial question: 
L236: « It is absolutely required that the used molecule [...] exhibits a good 
penetration through the OM and IM » => how is this routinely checked ?    
responses of the authors: 
- > This is checked after incubating the molecule with efflux-minus cells or in the
presence of CCCP.
& initial question: 
L310: How do the « CAZ fluorescent derivatives » differ from each other ? 
*Detailed Response to Reviewers
responses of the authors: 
-> Two fluorescent CAZ have been synthesized and used in this study. CAZ* is 
labelled with a coumarin and its fluorescent signal is not affected by cleavage by 
periplasmic <beta>-lactamases. Because we wanted to confirm the periplasmic 
localization of the translocated CAZ, CAZ** was synthesized. CAZ** is labelled with 
methoxyquinoline but becomes fluorescent only upon cleavage by periplasmic 
<beta>-lactamases.  
point that still must be corrected: 
>>> These explanations make perfect sense. We think that including them somehow 
in the final Ms would help the reader as they did help the reviewer ! 
This has been added in the new version. 
point #3 
initial question: 
L302: SICAR is certainly a very powerful and promising concept but a newcomer in 
the field would be interested to have a clear illustration of this concept. In particular 
the reader would be very interested to report how indeed   « physicochemical drug 
properties connects to the efficacy of translocation », as suggested in the text. 
However, there is no such description in Figure 4 ! In addition Panel 4E, although 
described in the « Legends for Figures », L630-635, is not shown.  
responses of the authors: 
-> We now refer to Vergalli J, Dumont E, Cinquin B, Maigre L, Pajovic J, Bacqué E, 
Mourez M, Réfrégiers M, Pagès JM. Fluoroquinolone structure and translocation flux 
across bacterial membrane. Sci. Rep. 2017;7(1):9821.   In this paper, we calculated 
SICAR(efflux) as the ratio of the accumulated antibiotic in Efflux minus to Efflux plus 
strains. Similar approach could be taken to calculate SICAR(influx).  
point that still must be corrected: 
>>> The reference Vergalli et al. indeed clarifies this point. However we still stress 
that Panel 4E is still lacking ! 
Sorry for this omission, This has been corrected. 
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Abstract 
To understand the antibiotic resistance in Gram-negative bacteria, a key point 
is to investigate antibiotic accumulation which is defined by influx and efflux. Several 
methods exist to evaluate the membrane permeability and efflux pump activity but 
they present some disadvantages and limitations. An optimized spectrofluorimetric 
method using the intrinsic tryptophan fluorescence as internal standard as well as a 
complementary microfluorimetric assay following the time-course accumulation in 
intact individual cells have been developed. Comparing the latter population and 
single cell approaches can lead to the understanding of the phenotypic heterogeneity 
within a population. The two methodologies lead to the determination of parameters, 
concentration, accumulation rates, localization that contribute to emerging concepts 
(RTC2T, SICAR) with the aim to identify and detail the antibiotic chemotypes that are 
involved in influx/efflux. 
Keywords 
Antibiotic; bacterial imaging; drug efflux pumps; Gram-negative bacteria; multidrug 
resistance; transporters 
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Introduction 
For several years antibiotic resistance has been an increasing threat to public 
health, it now concerns all major bacterial pathogens and antibiotic classes. A key 
challenge in antibiotic therapy is to determine the parameters modulating the in 
cellulo drug concentration required for a therapeutic action [1-3]. In Gram-negative 
antibacterial research, the concern is to evaluate the antibiotic permeation across the 
outer and inner membranes that constitute the bacterial envelope [4-6]. Translocation 
through the membrane barriers to reach the inhibitory concentration inside the 
bacterium is a pivotal step for antibacterial molecules [7-12].  
The discovery and the development of new antimicrobials mostly rely on their 
capacity to reach critical concentrations (Cinh) at the vicinity of their intracellular target 
[13,14]. Despite several decades of studies focused on antibiotic activity against 
bacterial cells using different approaches, no consensus for the analysis of the 
kinetics and accumulation of antibacterial agents in individual bacterium and in 
bacterial populations exists to understand the drug translocation into living bacteria 
as a first step of drug action [15]. Currently the lack of appropriate assays is a 
substantial bottleneck for the optimization of new molecules regarding permeability 
and to increase antimicrobial activity in intact bacterial cells. TRANSLOCATION 
consortium supports the development of reliable and robust methods to quantify 
penetration and efflux processes in Gram-negative bacteria (see "TRANSLOCATION 
Project: www.imi.europa.eu/content/translocation; [13]).  
Several methods and protocols have been developed in order to quantify and 
visualize the intra-bacterial concentrations of antibiotics and the role of membrane-
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associated mechanisms of resistance in the accumulation of antibacterial drugs 
(Influx, Efflux). Studies performed during this last decade have increased our 
understanding of how individual bacterial cells and bacterial populations control the 
internal concentration of antibiotics by using appropriate transport systems. In 
addition, original ways are now available to investigate in depth the drug 
translocation across bacterial membranes. Mass spectrometry appears as a 
promising method to determine the intracellular accumulation of label-free 
compounds [14,16]. Ultimately, this approach might help to characterize the 
permeability of various potential drugs, quantify antibiotic accumulation and meet the 
requirements of high throughput structure-activity relationship programs. In the case 
of naturally fluorescent drugs, intracellular accumulation can be monitored using a 
deep ultraviolet (DUV) light source that allows the detection by 
microspectrofluorimetry [17,18]. For example, fluoroquinolone antibiotics contain a 
quantum-yield of fluorescence sufficient to monitor their accumulation and 
localization in bacterial cells without requiring any addition of external probe.  
The information obtained by using these new approaches, combined with the 
knowledge inherited from more traditional approaches, are critical for our 
understanding of drug transport and have implications for future strategies and for 
designing new drugs to combat antibiotic resistance. 
Therefore, it is important to provide a recent and thoughtful perspective to the 
community that discusses the recent methods available for studying antibiotic 
penetration and correlation to antibacterial activities. From these studies and others, 
a new perspective emerges on how to capture and correlate the modes of action and 
kinetics of antibiotic uptake inside bacterial cells. 
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Detection of efflux activity 
The tripartite RND efflux pump family is well conserved in clinically relevant 
Enterobacteriaceae such as Escherichia coli, Enterobacter and Klebsiella spp, 
Salmonella enterica, as well as in other Gram-negative pathogens like Acinetobacter 
baumannii, Neisseria gonorrhoeae, and Pseudomonas aeruginosa [8,12].  
Based on its broad range substrate selectivity and its high expression level in 
clinical resistant isolates, it is a major contributor to the MDR resistance in these 
species. The archetypal E. coli AcrAB-TolC (or MexAB-OprM in P. aeruginosa) is the 
best structurally characterized RND efflux complex, since the crystal structures of the 
individual AcrA, AcrB and TolC have been solved and assembled complexes have 
been proposed [19-26].27]. While structural models and dynamic simulations are 
relatively well advanced (see accompanying reviews in this special issue), the 
characterization of AcrAB-TolC (as well as other efflux pumps) from mechanistic and 
kinetic point of view remains mainly partial as it relies on the comparison of minimal 
inhibitory concentration (MIC) values between of wild-type and acrAB-tolC deleted 
strains. 
The radiolabeled assay 
The first assay developed to evaluate the efflux activity in bacterial cells was the 
measurement of radiolabeled drug accumulation in resistant strains [28-30]. The 
efflux activity was demonstrated in several MDR isolates by using CCCP or other 
poisons that collapse the energy component of the efflux, and consequently block the 
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pump and restored the intracellular antibiotic concentration at a level similar to the 
normal susceptible reference strains. The radiolabeled assay presents some 
advantages about precision, sharpness of quantification but also large disadvantages 
regarding the availability/production of marked molecules, safety protocols, internal 
controls, low spatial resolution and waste treatments. 
The ethidium bromide-agar based method 
The accumulation of ethidium bromide (EtBr) was used to follow the activity of 
efflux pump in various bacterial species [31,32]. Later, a simple and instrument-free 
method that uses agar plates containing increasing concentrations of EtBr, as a 
fluorescent efflux pump substrate, has been developed to detect the presence of 
active efflux in swabbed strains [33]. This method, called the EtBr-agar cartwheel 
method, has been validated to identify overexpression of efflux pumps that contribute 
to MDR phenotypes in collections of clinical strains [34-37]. Briefly, it is based on that 
the minimal concentration of EtBr (MEB) in agar that produces fluorescence 
associated to bacteria growing at the surface of the agar defines the maximum 
extrusion rate of this substrate. Data showed that the MEB of strains that 
overexpress efflux pumps is considerably higher than that of reference strains. An 
example of results applied to one reference (ATCC15038) and eight MDR strains of 
E. aerogenes is shown: E. aerogenes HMEA11 showed no fluorescence at 1.5 µg/ml
EtBr whereas the others including ATCC15038 fluoresced at 0.05 µg/ml EtBr (Figure 
1).  
The main disadvantage of this method is the toxicity of the used dye, EtBr, the 
corresponding safety protocols require during the assays and the waste treatments of 
plates, effluents, etc. Moreover, like other dyes, EtBr is not per se an antibiotic and it 
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is difficult to correlate an internal concentration, to an antibiotic activity and a clinical 
relevance. 
The semi-automated “real-time” method using fluorescent probes 
It was necessary to develop fast, easy-to-perform and reliable methods in order to 
study the real-time efflux of a pre-accumulated compound in bacteria expressing 
various efflux pumps.  
Automated methods are advantageous in that they allow quantification of influx 
and efflux levels on a real-time basis and can be set up for medium throughput 
analysis of bacterial strains. The readability and reliability of this approach requires (i) 
that the chosen molecule does not alter bacterial metabolic functions at the working 
ranges, exhibits a good penetration through the outer membrane (and inner 
membrane), is a substrate of efflux pumps and yields high signal only when inside 
the cells and (ii) a protocol that detects the variation of this signal when molecules 
are expelled by the efflux activity.  
Several fluorescent probes for which the spectroscopic properties change upon 
entering the cells are particularly appropriate for these assays: the bacterial cells can 
be preloaded with these dyes before triggering the efflux by adding an energy 
source. Two lipophilic compounds, Nile Red and 1,2’-dinaphthylamine(1,2’-DNA) that 
give negligible fluorescence in aqueous solutions but become strongly fluorescent in 
nonpolar environments such as bacterial membranes, have been described for 
measuring the efflux activity and the effect of putative efflux pump inhibitors [38-41]. 
After loading, cells are then energized by the addition of glucose, which produces the 
proton motive force in the inner membrane, energizes the RND pump and triggers 
the dye efflux across the envelope (Fig. 2). However, special attention should also be 
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given to the self-quenching of the dye fluorescence in case of high concentration 
close to the bacterial membranes or to the quenching induced by other chemicals 
(e.g. efflux pump blockers/inhibitors) used in combination. In addition, similarly to 
EtBr, these molecules are not antibiotics and the correlation between internal 
concentrations and antibacterial activities are not possible. Moreover, an internal 
standard is required to efficiently compare the data obtained in various bacterial 
series. The efflux activity was demonstrated in several MDR isolates by using CCCP 
or other poisons that collapse the energy component of the efflux, and consequently 
block the pump and restore the intracellular antibiotic concentration at a level similar 
to the normal susceptible reference strains. Interestingly, this approach can also be 
used to screen for molecules that inhibit efflux [40,42].  
Monitoring β-lactam efflux using rates of β-lactamase-mediated hydrolysis 
The knowledge of the kinetic behavior of efflux pumps is essential in our attempts 
to understand and quantify their contribution to antibiotic resistance. No success was 
achieved until the Nikaido laboratory determined the kinetic constants for several β-
lactams, including penicillins and cephalosporins, in intact cells of E. coli [43-45]. 
First, the intracellular concentration of β-lactams, which accumulate in the periplasm, 
was calculated by from their hydrolysis rate by periplasmic β-lactamases. Then, the 
rate of efflux was calculated as the difference between the calculated rate of influx 
and the measured rate of hydrolysis. Results obtained with nitrocefin — a 
chromogenic cephalosporin — showed a Km of about 5 µM and a Vmax around 0.025 
nmol/mg/s, which correspond to a kcat  10/s based on the cellular content of AcrB. 
Overall, penicillins present a stronger apparent affinity ( 1 µM) for AcrB than 
cephalosporins (ranging from 5 to 300 µM). In contrast to nitrocefin, the other 
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cephalosporins had higher values of Km ( 20 µM for cefamandole,  90 µM for 
cephalotin,  300 µM for cephaloridine). Interestingly, this study showed that low 
affinity substrates such as cephaloridine are pumped out very efficiently (kcat  290/s) 
when the periplasmic concentration exceeds 100 µM, which is far superior to the MIC 
for this antibiotic ( 0.5 µM). This finding pointed that efflux is not that important as 
long as it occurs in the range of intracellular concentration superior to the MIC. 
Determination of antibiotic accumulation in bacteria using UV fluorescence 
microscopy/spectroscopy methods 
Membrane-associated mechanisms of bacterial MDR (i.e. membrane 
impermeability and drug efflux) act to efficiently limit the concentration of antibiotics 
at the vicinity of their targets. Therefore, a key point in the understanding of these 
mechanisms is to determine and compare the intracellular concentration of antibiotics 
in bacterial cells accordingly to their phenotypic and genotypic status. Several 
approaches have been developed in the past by using plate assays [46,47] and 
fluorimetry [48], mainly for measuring the accumulation of tetracyclines and 
fluoroquinolones by Enterobacteriaceae as reported previously [49,50]. 
Quinolones are powerful antibiotics that inhibit the activity of DNA gyrase and 
topoisomerase IV enzymes located in the cytoplasm. The ability of quinolones to 
pass the bacterial membranes to reach their intracellular targets is a key factor for 
their activity. In Gram-negative bacteria, fluoroquinolones have been shown to use 
the outer membrane porins [51] to efficiently accumulate inside the cell. The 
mechanism of permeation across the inner membrane is less clear, but most likely 
involves an energy-independent passive diffusion mechanism. Moreover, quinolones 
are also excellent substrates of efflux pumps [52,53]. 
10 
In 1989, Chapman & Georgopapadakou have developed a fluorimetric method 
based on the natural fluorescence of the quinolone nucleus present in 
fluoroquinolones such as the clinically used ciprofloxacin and norfloxacin [48]. 
Several adaptations have improved the spectrofluorimetry of cell lysates and allow a 
precise quantification of the antibiotic content (in ng/bacterial cell) in a given bacterial 
cell using a calibration curve. Various publications report the determination of 
fluoroquinolone concentration in various bacterial species [14].  
An optimized method to determine the fleroxacin accumulation inside Enterobacter 
aerogenes resistant strains that overproduced AcrAB-TolC efflux pump has been 
recently reported [17]. After incubation, the bacterial cells are washed onto a sucrose 
cushion in order to overcome problems of reproducibility mainly caused by non-
specific adsorption of antibiotic molecules at the bacterial surface [17]. Moreover, 
special attention has be given to the spectral properties of the fluorescent molecule 
(fleroxacin, ciprofloxacin) in order to monitor its fluorescence signal in bacterial 
lysates and to integrate an internal fluorescence standard, the intrinsic tryptophan 
fluorescence, in the protocol [17,54]. These special improvements have allowed 
generating comparative assays between various bacterial strains and species 
[18,54,55]. Furthermore, this internal standard that insures the quantitative valuation 
of various drugs/antibiotics on different bacterial strains is necessary for a 
comparative validation of other methods (such as mass spectrometry) for which no 
intrinsic standard has been selected yet.  
About E. aerogenes and E. coli strains, the data indicate that the steady-state 
accumulation was stable after an incubation time of 10-15 minutes for the strains 
without AcrAB or overproducing the efflux pump. The CCCP addition during the 
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assay with AcrAB overproducer strain restores the accumulation plateau observed in 
the acrAB deleted strain (Fig. 3). To reach the best validation and robustness interval 
of this approach it is absolutely required that the used molecule (i) does not kill the 
bacteria at the used concentration during the incubation times, a parameter which 
can be checked by survival assays, (ii) exhibits a good penetration through the outer 
membrane (and inner membrane), (iii) is a substrate of efflux pumps as documented 
by the susceptibility determined in isogenic strains in parallel, and by using efflux-
deleted cells or incubation in the presence of CCCP [17], and (iv) importantly cause 
non-overlapping signal with the intrinsic internal standard (e.g. tryptophan signal). 
Moreover, the signal must be detected in intact bacterial cell 
(microspectrofluorimetry) and in bacterial lysates by using the same antibiotic 
concentration and generate significant variation when molecules are expelled by the 
efflux activity. Interestingly, this method has indicated some discrepancy in the 
fluoroquinolone accumulation in a bacteria population issued from the same resistant 
strain treated with the ionophore suggesting some phenotypic heterogeneity [17]. 
Combining population and single cell approaches guarantee that, if several 
subpopulations with extreme behavior were present, they would not be 
underestimated. 
It can be noted that a fluorescent ß-lactam derivative has been recently used to 
study the antibiotic accumulation and susceptibility in bacterial persisters, a sub-
population dormant bacteria showing high level of tolerance to antibiotics [56]. 
Bocillin is a penicillin V molecule coupled to a fluorescein core, BODIPY FL dye 
(which is spectrally similar to fluorescein). This compound has been assayed to 
measure the activity of efflux pump on its intra-bacterial accumulation [57]. 
Interestingly, the authors reported that the internal accumulation of bocillin was 
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significantly reduced in persisters due to the efflux activity of AcrAB-TolC pump [57]. 
Bocillin was also used for evaluating the role of efflux pump in the resistance of non-
typeable Haemophilus influenzae [58]. Although this fluorescent penicillin derivative 
is an interesting tool, it must be mentioned that due to the involvement of porin 
channel during the uptake of this antibiotic family, an alteration of porin 
characteristics (expression level, porin type or channel conductance) can change the 
accumulation rate and consequently can perturb the determination of efflux activity 
[6,8]. 
Fluoroquinolone time-course accumulation in a single bacterial cell using UV 
fluorescence microscopy, microfluorimetric assay 
Optimized spectrofluorimetric and microscopic methods using appropriate 
calibration curves and internal standards have been developed to monitor the 
accumulation of fluoroquinolones in Enterobacteriaceae. More recently, these 
approaches have been modified for the measurement of antibiotic accumulation in 
intact individual cells: briefly the bacterial cells are deposited between two quartz 
coverslips and analysed by DUV microspectrofluorimetry and/or by DUV 
fluorescence imaging (Fig. 4). The cell viability was checked during the time 
exposure. With this protocol, the time-course of accumulation of selected 
fluoroquinolones can be recorded in different individual cells [54] and with various 
incubation conditions (antibiotic concentration, efflux blocker, etc). The rate of 
accumulation and the plateau reached after long time of incubation can be extracted 
for a given antibiotic and for a given strain [54]. 
These technologies will offer the opportunity to determine influx and efflux 
parameters such as the intracellular concentration of antibiotics (Cin), the critical 
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inhibitory intracellular concentration of antibiotics (Cinh), the precise contribution of 
limiting factors in reaching a Cinh (e.g. porins and efflux pumps) and the influence of 
chemical moieties (pharmacophores) within a specific class of antibiotic. The 
"Resident Time Concentration Close to Target" (RTC2T) concept includes the 
precise determination of both Cin, and Cinh for a given antibacterial molecule for a 
given bacterial strain [14]. It will be useful to quantify the biological activity of different 
adjuvants in increasing the intracellular concentration of specific antibiotics in strains 
exhibiting membrane-associated mechanisms of resistance. The translocation of 
antibiotics belonging to different classes through bacterial membranes via outer 
membrane pores or transporters (porins or efflux pumps) is a relatively fast event and 
the steady-state concentrations are generally reached after short incubation times. 
Monitoring real-time accumulation of different quinolones showed different 
accumulation kinetics and steady-state accumulation levels depending on the 
properties (chemical and structural) of the compound in a selected bacterial 
background. From these observations a new concept, "Structure Intracellular 
Concentration Activity Relationship" (SICAR) can be elaborated to dissect the profile 
of antibacterial molecules [14]. SICAR connects the physicochemical drug properties 
to the efficacy of translocation through the bacterial membrane and the resulting 
intracellular accumulation [59]. 
These concepts have been recently used to dissect the role of chemical structures 
and the bacterial elements which are involved in influx (uptake) or in efflux, and guide 
rationale pharmacomodulation of side chains to fine-tune molecular interactions with 
membrane transporters. Two cases have been studied so far: an antibiotic having a 
periplasmic target and one having a cytoplasmic target, this gives the possibility to 
integrate the aspect about the cellular location.  
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Ceftazidime (CAZ) is a potent cephalosporin to treat resistant bacteria in 
combination with ß-lactamase inhibitors [60]. Different fluorescent derivatives have 
been synthesized to dissect the early step of translocation across bacterial outer 
membrane.: CAZ* is labeled with a coumarin and its fluorescent signal is not affected 
by cleavage by periplasmic ß-lactamases, and CAZ** is labeled with 
methoxyquinoline but becomes fluorescent only upon cleavage by periplasmic ß-
lactamases [55]. The measure of internal accumulation and activities are performed 
on clinical resistant strains expressing various levels of porins and ß-lactamases. By 
using microspectrofluorimetry and epifluorimetry, the translocation of CAZ to the 
periplasmic space was followed when the outer membrane barrier was permeabilized 
[55]. This study demonstrated the relationship between periplasmic accumulation and 
antibiotic activity by approaching ß-lactam permeation relative to membrane 
permeability. Moreover, a correlation between internal accumulation and ß-lactamase 
activity was provided that supports the pioneer model proposed by H. Nikaido to 
explain the interplay existing between the membrane and enzymatic barrier for ß-
lactams [61,62]. 
Three selected fluoroquinolones have been studied for their accumulation in 
bacterial population and inside individual Gram-negative bacterial cells that express 
various levels of efflux pumps. For a given fluoroquinolone library, these assays 
allowed the determination of SICARIN and SICAREF indexes, the first one reflects 
“structure-to-penetration” relationships and the second one illustrates the correlation 
“structure-to-efflux”. This original approach validates the SICAR concept [14,59] and 
demonstrates the expected benefit by evidencing some pharmacophoric groups that 
can be involved in the penetration and in the efflux.  
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Reconstitution of efflux pumps in proteoliposomes 
Active drug transport by efflux pumps has also been investigated after 
reconstitution of purified proteins into proteoliposomes. A major difficulty is to 
generate quantitatively measurable and reproducible proton gradient across the 
liposome membrane. Primary in vitro transport assay has been designed by the 
Nikaido laboratory, in which reconstituted E. coli AcrB were energized by a proton 
gradient generated by the addition of valinomycin, a potassium-ionophore [63]. 
Detection of proton transport was monitored using pyranine, a lipophilic and pH-
dependent fluorescent probe. However, the stability of the valinomycin-generated 
ΔpH was strongly influenced by the batches of lipids used for reconstitution and other 
factors [64]. To overcome this problem, Picard and colleagues have developed an 
original system in which they used bacteriorhodopsin (BR) from Halobacter halobium 
to generate a photo-induced proton gradient to activate the MexB efflux pump from 
P. aeruginosa [65]. In this system, BR, MexA and MexB were reconstituted in
liposomes containing pyranine. After illumination of the proteoliposomes, BR 
generates a transmembrane proton gradient, which is then used by MexB to 
transport a fluorescent dye (Hoechst 33342). In this assay, pyranine fluorescence is 
monitored while the proton gradient is generated or dissipated as a result of MexB 
efflux activity (Fig. 5). Curves show that MexB is active only in the presence of the 
periplasmic adaptor MexA. Recently, significant improvements of this method have 
been made by combining proteoliposomes containing the MexAB and OprM portions 
of the complex. This allowed monitoring of transport by the tripartite MexAB-OprM 
pump in a system that mimics the dual-membrane architecture of Gram-negative 
bacteria [26, 66]. 
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Conclusion 
Today with the development of DUV-fluorimetry method and apparatus, new tools 
have been proposed for studying the drug translocation across biological membrane 
and in living cells including bacterial population and individual bacterial cells.  
Boosted by emerging and upgraded methodologies (detector, filters, etc), new 
concepts such as “Structure Intracellular Concentration Activity Relationship” 
(SICAR) and "Resident Time Concentration Close to Target" (RTC2T), have been 
proposed in order to bridge the molecular and membrane transport aspects [14]. 
Using RTC2T and SICAR methodologies, a new dissection of antibiotic translocation-
transport can be defined to better understand and improve the antibiotic chemotypes 
that are related to permeation and efflux. The final objective will be to enhance the 
antibacterial efficacy of a rationally synthetized antibiotic against a resistant species.  
A second important aspect is the complex relation integrating 
"kinetics/localization/concentration" inside the bacterial cell and the effect on bacterial 
metabolism and cell life. An important step is to correlate the intracellular 
concentration threshold and antibacterial activity for the antibiotic molecule and also 
for new "adjuvants" that can improve the antibiotic concentration inside the 
bacterium. 
Conclusively, the use of this methodology that measures the real-time 
accumulation in different bacterial phenotypes and takes into account various 
chemical structures, allows analyzing the molecular bases of drug translocation. 
Consequently, the concept of "structure intracellular concentration activity 
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relationship" previously proposed [14] can be extensively studied for fluorescent 
antibiotics. Regarding non-fluorescent molecules, a competitive assay can be 
designed to indirectly measure these parameters, or alternatively mass spectrometry 
quantification can be successfully applied [67-69]. About mass spectrometry, the 
precision of the method asks for a robust internal standard that could be used to 
standardize the assays carried out with various bacterial species and various strains 
including clinical isolates. 
By using these methods available in microplates, the role of chemical side chains 
involved in the membrane permeation or in the efflux transport [59] can be dissected 
to better design drug side chains fitting well with the translocation constraints.  
The future step will be the development of microfluidic-microfluorimetric approach 
that detect two events in the same bacterial cell, influx and efflux. This detection, 
should finally allow the discrimination inside the population of susceptible 
(fluorescence signal) and low-susceptible (no signal) individual bacteria present 
under specific conditions. This multiplexed approach paves the way for studying the 
diversity in the population, the presence of persisters, and the role of membrane-
associated mechanisms of resistance in the bacterial response face to the antibiotic 
stimulus. 
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Legends for Figures 
Figure 1: Identification of efflux pump-mediated multidrug-resistant bacteria by the 
ethidium bromide-agar cartwheel method.  
Left: Cartwheel pattern for the swabbing of the bacterial strains tested by the EtBr-
agar cartwheel method. Controls and clinical isolates were swabbed on an EtBr-
containing agar plate, according to the diagram.  
Right: Example of the EtBr-agar cartwheel method applied to Enterobacter 
aerogenes strains on agar plates containing 1.5 mg/l of EtBr. Following overnight 
incubation at 37°C for 16 hours, fluorescence was detected under UV light. (from 
[34]). 
Figure 2: Real-time efflux assay using fluorescent probes. 
(A) Protocol of the real-time efflux method. The cells are preloaded with a dye which
is fluorescent in nonpolar environments such as bacterial membranes. Addition of 
glucose energizes the efflux pump and triggers the dye efflux across the envelope, 
leading to the decrease of fluorescence.  
(B) Representative 1,2′-DNA efflux curves of E. aerogenes EA289, a clinical isolate
overexpressing AcrAB efflux pumps, and EA298 its tolC- derivative. Fluorescence of 
the AcrAB overexpressing strain is decreasing while the fluorescence of the strain 
devoid of TolC is stable. 
Figure 3: Determination of antibiotic concentration in bacteria using 
spectrofluorimetry. 
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(A) Protocol of the spectrofluorimetry method: After incubation of bacteria with the 
antibiotic, bacteria cells are washed onto a sucrose cushion in order to avoid non-
specific adsorption on the cell surface. The cells are then lysed overnight and the 
fluorescence intensity of the intracellular content is measured.  
(B) Representative fluorescence curves corresponding to the lysates of the
overexpressing AcrAB efflux pump strain E. aerogenes EA289 and its tolC- derivative 
strain EA298, incubated with fleroxacin with or without CCCP.  
Upper panel: kinetic of fleroxacin accumulation in the cells during 1h of incubation.  
Lower panel: Peaks of fluorescence (corresponding to the fleroxacin emission 
wavelength) of the lysates sampled at 15 minutes of incubation. 
Figure 4: Fluoroquinolone time-course accumulation in individual bacterial cells 
using DUV microspectrofluorimetry.  
(A) Average fluorescence intensity time course of 100 individual cells of the
overexpressing AcrAB efflux pump strain E. aerogenes EA289 (solid line) and its 
tolC- derivative strain EA298 (dashed line) incubated with fleroxacin. (from [53]).  
(B) Images taken by microscopy of isolated bacterium accumulating fleroxacin. (C)
Antibacterial activities and spectral properties of fleroxacin. MIC (Minimal inhibitory 
concentration) are indicated in mg/L; PMBN (Polymyxin B nonapeptide) was used at 
51.2 mg/L, PAßN (Phenylalanine-arginine-ß-naphthylamide) at 20 mg/L and CCCP 
(carbonyl cyanide m-chlorophenylhydrazone) at 10 µM. (D) Scheme of the 
translocation of fleroxacin (FLX) in a gram-negative bacterial cell. [FLX]ext: 
Concentration of fleroxacin in the external environment, [FLX]pp in the periplasmic 
space, [FLX]cyt in cytoplasm. (E) Microspectrofluorimetry on bacterial cells incubated 
with fleroxacin (Fle) for 10 min. In the parental strain, AG100, the fluorescence was 
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less intense that the ones obtained in AG100A, the AcrAB deleted strain. When the 
incubation of the efflux overproducer strain (AG102) was performed in the presence 
of CCCP that collapse the energy driving force of efflux pump, a signal similar to 
those in AG100A was obtained. 
Figure 5: Reconstitution of efflux pumps in proteoliposomes. 
(A) Schematic representation of the MexA-MexB-OprM pump from Pseudomonas
aeruginosa (Adapted from [64]). 
(B) Cartoon representation of liposomes reconstituted with bacteriorhodopsin (BR)
from Halobacter halobium (upper scheme) or with both BR and MexB were 
reconstituted in liposomes containing pyranine (lower scheme). BR is used to 
generate a photo-induced proton gradient to activate the MexB efflux pump. After 
illumination of the proteoliposomes, BR generates a transmembrane proton gradient, 
which is then used by MexB to transport a fluorescent dye. (C) Monitoring of the 
liposomal acidification upon illumination. Pyranine fluorescence variations, as a result 
of MexB efflux activity, were normalized to the corresponding pH variations based on 
titration of the fluorescence variation as a function of pH. MexB is active only in the 
presence of the periplasmic adaptor MexA. 
